Boston Globe Examines U.S. Global Health Strategy
The Boston Globe examines the U.S. strategy towards global health aid.
PEPFAR
Refine Results
Recent Releases: PEPFAR and IDUs; Economic Crisis and Health; Human-Rights and Pharmaceutical Companies
Lancet Commentary Examines How PEPFAR Failing To Reach IDUs Although PEPFAR has helped to provide “antiretroviral therapy to 2.1 million people with HIV, almost all of whom live in sub-Saharan Africa, and has spent more than US$18 billion on the continent” it has failed to reach “thousands of injecting drug…
NewsHour Features Two Health Experts On President Obama’s Global Health Initiative
On the News Hour Insider Forum, Ray Suarez interviews global health experts Michele Moloney-Kitts, assistant U.S. global AIDS coordinator, and Christine Lubinski, head of the Center for Global Health Policy and Advocacy about President Obama’s $63 billion global health initiative.
Kenya Seeks Support From PEPFAR To Expand Blood Transfusion Centers
Kenya’s Medical Services Permanent Secretary James Ole Kiyiapi announced Thursday that the government is in negotiations with PEPFAR for support in building additional blood transfusion centers in the country, Capital News reports.
Effort Launched To Strengthen African Medical Labs
The U.S., WHO and representatives from 13 African countries on Monday launched an effort to boost the standards for quality medical labs on the continent, VOA News reports.
Opinion: Local Drug Production In Developing Countries; Obama’s PEPFAR Changes
Local Drug Production Doesn’t Increase Access, Undermines Quality The international community focuses on lowering drug prices as a means of improving access and “today its idea is local pharmaceutical production … But while the German Government and other countries’ aid agencies are helping fund small firms in Africa, they have…
BBC Examines ‘Huge Imbalance’ Between Funding For HIV/AIDS, Other Health Needs In Uganda
The BBC examines the balance between funding for HIV/AIDS and for the broader health system and other diseases in Uganda.
FDA Approves 100th Antiretroviral For PEPFAR
HHS recently announced the FDA’s 100th approval of an antiretroviral drug for PEPFAR, PharmTech.com reports. Seventy-one of the more than 100 drugs reviewed by FDA for PEPFAR were generic products. HHS Secretary Kathleen Sebelius said in a statement, “This milestone exemplifies the dedication, caring, and hard work of all who strive to better the lives of those infected with or affected by HIV/AIDS” (10/15).
Opinions: Pragmatic Vs. Moral Approach To Health Care Access; Pres. Bush’s PEPFAR
Rights Advocacy Not The Best Approach For Global Health “[T]he global campaign to equalise access to healthcare has had a surprising result: it has made global healthcare more unequal,” William Easterly, a professor of economics at New York University and co-director of its Development Research Institute, writes in a Financial Times…
Kaiser Family Foundation, CSIS Host Panel Discussion On IOM’s PEPFAR Evaluation
On Tuesday, April 30, from 2:00-3:30 p.m., the Kaiser Family Foundation and the Center for Strategic and International Studies (CSIS) Global Health Policy Center will host a panel discussion, titled “The Policy Implications of the Institute of Medicine’s Evaluation of PEPFAR,” at the CSIS conference center in Washington, D.C. Moderated…